Title:
8-ETHYL-6-(ARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
Document Type and Number:
WIPO Patent Application WO/2011/044535
Kind Code:
A3
Abstract:
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
Inventors:
VOLLRATH BENEDIKT (US)
CAMPBELL DAVID (US)
DURON SERGIO G (US)
WADE WARREN (US)
CAMPBELL DAVID (US)
DURON SERGIO G (US)
WADE WARREN (US)
Application Number:
PCT/US2010/052106
Publication Date:
August 18, 2011
Filing Date:
October 08, 2010
Export Citation:
Assignee:
AFRAXIS INC (US)
VOLLRATH BENEDIKT (US)
CAMPBELL DAVID (US)
DURON SERGIO G (US)
WADE WARREN (US)
VOLLRATH BENEDIKT (US)
CAMPBELL DAVID (US)
DURON SERGIO G (US)
WADE WARREN (US)
International Classes:
C07D471/04; A61K31/519; A61P25/18; A61P25/24; A61P25/28; C07D409/14; C07D413/14
Domestic Patent References:
| WO2002064594A2 | 2002-08-22 |
Foreign References:
| US20020107171A1 | 2002-08-08 |
Other References:
See also references of EP 2486037A4
Attorney, Agent or Firm:
WILSON SONSINI GOODRICH & ROSATI et al. (Palo Alto, California, US)
Download PDF: